MEN1 and pancreatic neuroendocrine tumor: According to the MEN consensus panel, the clinical diagnosis of this syndrome is based on the concomitant occurrence of at least two of the three MEN1-related endocrine tumours (parathyroid adenoma, pituitary adenoma, pancreatic NET).